These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5362109)

  • 1. [Indications and treatment of menstrual disorders with a synthetic progestational hormone, ethynodiol diacetate alone or combined in variable doses with an estrogen].
    Soutoul JH
    Rev Fr Gynecol Obstet; 1969; 64(1):41-55. PubMed ID: 5362109
    [No Abstract]   [Full Text] [Related]  

  • 2. [1st results with the ethynodiol diacetate-mestranol combination].
    Mancuso S
    Minerva Ginecol; 1966 Apr; 18(8):433-7. PubMed ID: 5920234
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ovulen in the treatment of the premenstrual syndromes in psychiatric patients].
    Rasmussen R; Hagen A; Ravn J
    Ugeskr Laeger; 1967 Feb; 129(7):224-6. PubMed ID: 5599219
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of synthetic steroid preparations for hemostasis and normalization of menstrual function in juvenile hemorrhages].
    Kuznetsova MN; Antipina NN; Zagorskaia EA
    Vopr Okhr Materin Det; 1978 Feb; 23(2):77-80. PubMed ID: 347706
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of meno-metrorrhagia of functional origin by an estro-progestational compound: ethynodiol diacetate combined with mestranol].
    Dumont M; Thoulon JM
    Lyon Med; 1967 Jun; 217(25):1847-52. PubMed ID: 5610232
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of a low dosage estrogen-progestational combination (FH 027-A)].
    Villedieu P
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):329-36. PubMed ID: 5711745
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytologic and colposcopic findings before and after administration of ovulation inhibitors].
    Loskant G; Heinen G
    Zentralbl Gynakol; 1968 May; 90(18):609-13. PubMed ID: 5722983
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with ethynodiol diacetate combined with mestronal (metrulen).
    McGoogan LS
    Nebr State Med J; 1968 Jul; 53(7):341-3. PubMed ID: 4232054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
    Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
    Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our clinical experience with ethynodiol diacetate, alone or combined in variable doses with mestranol].
    Colin R
    Gynecol Obstet (Paris); 1966; 65(4):537-43. PubMed ID: 5971381
    [No Abstract]   [Full Text] [Related]  

  • 11. Indications for therapy with progestational agents.
    Darragh A
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):541-4. PubMed ID: 5534331
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of a synthetic estro-progestational agent: FH 080].
    Villedieu P
    Presse Med (1893); 1966 Nov; 74(51):2625-6. PubMed ID: 5926994
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic indications and results of 8080 CB in gynecology].
    Girard M
    Rev Fr Gynecol Obstet; 1965 Apr; 60(4):281-93. PubMed ID: 5889838
    [No Abstract]   [Full Text] [Related]  

  • 14. [Oral treatment of prolonged dysfunctional bleedings with estrogen-gestagen preparations].
    Rehsteiner HP
    Zentralbl Gynakol; 1969 Feb; 91(6):178-86. PubMed ID: 5405176
    [No Abstract]   [Full Text] [Related]  

  • 15. [Induction of uterine hemorrhage using 17-alpha-ethynyl-4-estrene-3-beta, 17-beta-diol diacetate (ethynodiol diacetate)].
    Tanaka Y
    Sanfujinka No Jissai; 1969 Feb; 18(2):185-7. PubMed ID: 5818867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experience with an estrogen-progestogen association with low estrogen content (ethinodiol-ethinylestradiol)].
    Andreoli C; Fiorentino F; Lenzi G
    Quad Clin Ostet Ginecol; 1970 Jan; 25(1):15-28. PubMed ID: 5523807
    [No Abstract]   [Full Text] [Related]  

  • 17. [Decrease of hypertrichosis and of urinary 17-ketosteroids (A+E) in women with ovarian pilary virulism treated with synthetic progestational hormones].
    Dumitrache C; Tomov-Vlad A; Simescu M; Bunea M
    Stud Cercet Endocrinol; 1972; 23(2):119-24. PubMed ID: 5070559
    [No Abstract]   [Full Text] [Related]  

  • 18. [FH 027 in the treatment of dysmenorrhea].
    Kolenc M
    Bord Med; 1970 May; 3(5):1409-10. PubMed ID: 5425890
    [No Abstract]   [Full Text] [Related]  

  • 19. Basaloid adenoma in the breast of woman treated with oral contraceptives.
    Albert W; Stasiak K; Kibler J
    Patol Pol; 1980; 31(4):597-601. PubMed ID: 7243355
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose intolerance during ethynodiol diacetate--mestranol therapy.
    Halling GR; Michals EL; Paulsen CA
    Metabolism; 1967 May; 16(5):465-8. PubMed ID: 6025024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.